Systechone
The cost of returned medicines is estimated to be between $5-10 billion per year in the US alone. However, pharmaceutical companies are struggling to streamline the data flow and verification of returned saleable goods.
Watch Now
Registration fees are refundable for attendees registered for individual webinars, if cancellation is received at least five (5) business days prior to the course.
Watch Now
pharmtech
Economic performance could soon replace compliance as the leading quality goal for pharmaceutical companies.
According to the 2019 Pharma Quality Outlook Survey, 66% of industry executives named compliance as a top goal, down 10% from last year. Meanwhile, more than one-third (39%) say that economic performance is now their top objective, a 4% increase.Join Sparta System's Steve McCarthy, VP of Digital Innovation, as he discusses key findings from this year's survey, which included responses from 161 professionals.
Watch Now
.jpg)
Discover how you can easily meet upcoming national regulations on serialization of drugs to ensure patient safety
Watch Now